Rapamycin, eicosapentaenoic acid and epigallocatechin-3-gallate for the prevention of WNT-driven Colorectal Cancer

Responsabile scientifico: prof. Ricciardiello Luigi

Ente finanziatore: AIRC

Durata: 02/01/2021 - 01/04/2022